The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mcdevitt Damien since 2019.
The trader's CIK number is 1742277.
At the time of the last reporting, Mcdevitt Damien was the Chief Executive Officer of Akcea Therapeutics, Inc.. (stock ticker symbol AKCA).
Also see all insider trading activities at Akcea Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2019 | IONS | 0 | $0 | 0 | $0 | 3,542 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | AKCA | 0 | $0 | 18,126 | $268,456 | 0 | $0 |
1. Ionis Pharmaceuticals Inc (IONS)
2. Akcea Therapeutics, Inc. (AKCA)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-07-15 | IONS | Option Ex | 3,542 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-09-22 | AKCA | Sale | 8,709 | 18.12 | 157,807 |
2020-03-23 | AKCA | Sale | 9,417 | 11.75 | 110,649 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mcdevitt Damien (Chief Executive Officer of Akcea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.